Charles Schwab’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,699
| Closed | -$152K | – | 3665 |
|
|
2022
Q1 | $152K | Sell |
12,699
-1,574
| -11% | -$18.8K | ﹤0.01% | 3350 |
|
|
2021
Q4 | $466K | Sell |
14,273
-6
| -0% | -$196 | ﹤0.01% | 3171 |
|
|
2021
Q3 | $639K | Sell |
14,279
-24,901
| -64% | -$1.11M | ﹤0.01% | 3057 |
|
|
2021
Q2 | $2.14M | Buy |
39,180
+2,863
| +8% | +$156K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $2.72M | Buy |
36,317
+12,022
| +49% | +$899K | ﹤0.01% | 2562 |
|
|
2020
Q4 | $2.64M | Sell |
24,295
-16
| -0.1% | -$1.74K | ﹤0.01% | 2521 |
|
|
2020
Q3 | $2.15M | Sell |
24,311
-778
| -3% | -$68.8K | ﹤0.01% | 2471 |
|
|
2020
Q2 | $2.68M | Buy |
25,089
+4,572
| +22% | +$487K | ﹤0.01% | 2312 |
|
|
2020
Q1 | $1.22M | Sell |
20,517
-18
| -0.1% | -$1.07K | ﹤0.01% | 2441 |
|
|
2019
Q4 | $1.42M | Buy |
20,535
+626
| +3% | +$43.3K | ﹤0.01% | 2504 |
|
|
2019
Q3 | $2.07M | Sell |
19,909
-488
| -2% | -$50.7K | ﹤0.01% | 2363 |
|
|
2019
Q2 | $1.89M | Buy |
20,397
+9,108
| +81% | +$844K | ﹤0.01% | 2387 |
|
|
2019
Q1 | $1.03M | Sell |
11,289
-1,414
| -11% | -$129K | ﹤0.01% | 2540 |
|
|
2018
Q4 | $708K | Sell |
12,703
-203
| -2% | -$11.3K | ﹤0.01% | 2644 |
|
|
2018
Q3 | $1.54M | Buy |
12,906
+1,697
| +15% | +$202K | ﹤0.01% | 2503 |
|
|
2018
Q2 | $1.15M | Buy |
11,209
+3,535
| +46% | +$361K | ﹤0.01% | 2549 |
|
|
2018
Q1 | $997K | Buy |
7,674
+3,331
| +77% | +$433K | ﹤0.01% | 2513 |
|
|
2017
Q4 | $423K | Buy |
4,343
+172
| +4% | +$16.8K | ﹤0.01% | 2770 |
|
|
2017
Q3 | $614K | Buy |
4,171
+2,041
| +96% | +$300K | ﹤0.01% | 2658 |
|
|
2017
Q2 | $343K | Buy |
+2,130
| New | +$343K | ﹤0.01% | 2816 |
|